HCPLive

Opioid-induced Constipation 
The MD Magazine Opioid-induced Constipation condition center provides clinical news and articles, information about upcoming conferences and meetings, updated clinical trial listings, and other resources.

Latest Headlines

Five Categories of Lower Gastrointestinal Functional Bowel Disorders in Revised Rome IV Criteria
The new Rome IV criteria classify the functional bowel disorders into five distinct categories, including irritable bowel syndrome (IBS), functional constipation, functional diarrhea, functional abdominal bloating/distention, and unspecified functional bowel disorder. A new category for opioid-induced constipation, which is distinct from the functional bowel disorders, has been added.
Rome IV updates include more specific definitions and diagnostic criteria for functional gastroduodenal disorders such as functional dyspepsia, belching disorders, and nausea and vomiting disorders.
The Rome Foundation announced the release of updated and revised Rome IV diagnostic criteria for more than 20 different gastrointestinal disorders at DDW 2016.
The field of gastroenterology is as wide as the the amount of the body that it covers. Because of this there are certain challenges doctors face whether they treat the entire gastrointestinal system or just specific parts.
As patients seek help for chronic and acute pain problems doctors and health care professionals continue to seek new treatment options beyond surgery and medication.
With a continually growing opioid addiction new guidelines have been adopted looking to help fight this problem across the population. Some concerns have been raised about whether this will cause doctors to shy away from prescribing the medications for patients who can benefit most from them.
Temple University Researchers suggest that a guideline created by Temple University Hospital and Temple University Hospital-Episcopal Campus for prescribing opioids in order to maximize safety and avoid misuse appears to significantly decrease the rate of opioid prescribing for minor and chronic non-cancer pain complaints in an acute care setting.
The number of opioid-related deaths nearly quadrupled from 1999 to 2011 in the US; and while that number continues to increase, one state has made positive strides with the implementation of two initiatives.
Researchers who looked at the potential association between post-diagnosis opioid use and breast cancer recurrence found no clinically relevant evidence of an association between opioid prescriptions and breast cancer recurrence.

Most Popular

@MDMagazine

$vacMongoViewPlus$ $vAR$